![epa08600510 A handout photo made available by the Russian Direct Investment Fund (RDIF) shows a scientist of Nikolai Gamaleya National Center of Epidemiology and Microbiology working on the production of a new two-vector COVID-19 vaccine in Moscow, Russia, 06 August 2020 (issued 13 August 2020). Russia registered the new called Sputnik V vaccine against the coronavirus Sars-Cov-2 and opens the stage of its massive testing. EPA/RDIF HANDOUT NO RESTRICTIONS, ALLOW TO USE IN SOCIAL NETWORK HANDOUT EDITORIAL USE ONLY/NO SALES](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/UICYYFRR3L726GNFPOOUMVYZYU.jpg?smart=true&auth=247853a80024fe52b5b0ded67841b65080c6d0dd9bfb5a222bb9714510e95448&width=400&height=225)
epa08600510 A handout photo made available by the Russian Direct Investment Fund (RDIF) shows a scientist of Nikolai Gamaleya National Center of Epidemiology and Microbiology working on the production of a new two-vector COVID-19 vaccine in Moscow, Russia, 06 August 2020 (issued 13 August 2020). Russia registered the new called Sputnik V vaccine against the coronavirus Sars-Cov-2 and opens the stage of its massive testing. EPA/RDIF HANDOUT NO RESTRICTIONS, ALLOW TO USE IN SOCIAL NETWORK HANDOUT EDITORIAL USE ONLY/NO SALES
epa08600510 A handout photo made available by the Russian Direct Investment Fund (RDIF) shows a scientist of Nikolai Gamaleya National Center of Epidemiology and Microbiology working on the productionShow more
Russia starts production of Covid-19 vaccine
Moscow says the vaccine will be introduced by the end of August
![The National](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/https%3A%2F%2Fs3.amazonaws.com%2Farc-authors%2Fthenational%2F9e2159fa-e4db-4215-b498-6b3607b75bee.png?smart=true&auth=cf728de2f2d93afc214682199f23d53c844677eb59567fe99abdb1c7e9f03161&width=70&height=70)
The National
15 August, 2020
- Listen In English
- Listen In Arabic